Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis \(AD\)”

220 trials

Showing 20 of 220 results

Large-scale testing (Phase 3)Study completedNCT01244230
What this trial is testing

Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Sanofi 100
Not applicableActive Not RecruitingNCT05081557
What this trial is testing

Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 873
Not applicableStudy completedNCT07323719
What this trial is testing

Comparison Between Topical N-acetyl Cysteine (NAC) in Cold Cream Versus Cold Cream in Mild and Moderate Atopic Dermatitis: Clinical and Bacteriological Evaluation. A Randomized Control Trial.

Who this might be right for
Atopic Dermatitis (AD)
Cairo University 100
Testing effectiveness (Phase 2)UnknownNCT04725136
What this trial is testing

Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 96
Early research (Phase 1)Looking for participantsNCT07146971
What this trial is testing

Clinical Evaluation of Skin Microbiome an Over-The-Counter (OTC) Drug for Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Good Molecules, LLC 36
Testing effectiveness (Phase 2)Ended earlyNCT04220411
What this trial is testing

AR100DP1 in Mild to Moderate Atopic Dermatitis (AD)

Who this might be right for
Dermatitis, Atopic
Arjil Pharmaceuticals LLC 17
Post-approval studies (Phase 4)Study completedNCT04033367
What this trial is testing

SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"

Who this might be right for
Atopic Dermatitis
Sanofi 188
Not applicableNot Yet RecruitingNCT06687512
What this trial is testing

A Clinical Study to Assess the Safety and Effectiveness of Test Products in Mild to Moderate Atopic Dermatitis (AD) Patients.

Who this might be right for
Atopic Dermatitis
NovoBliss Research Pvt Ltd 44
Post-approval studies (Phase 4)Study completedNCT00925730
What this trial is testing

Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion

Who this might be right for
Atopic Dermatitis
Novartis 20
Early research (Phase 1)Study completedNCT05405985
What this trial is testing

Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber Syringe

Who this might be right for
Healthy Volunteers
Galderma R&D 192
Large-scale testing (Phase 3)Active Not RecruitingNCT05882877
What this trial is testing

Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 2,621
Testing effectiveness (Phase 2)Study completedNCT03151148
What this trial is testing

Targeted Microbiome Transplant in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
National Institute of Allergy and Infectious Diseases (NIAID) 54
Large-scale testing (Phase 3)Study completedNCT05899816
What this trial is testing

A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)

Who this might be right for
Atopic DermatitisModerate-to-severe Atopic Dermatitis
Amgen 221
Not applicableActive Not RecruitingNCT05139836
What this trial is testing

Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting

Who this might be right for
Atopic Dermatitis
AbbVie 634
Testing effectiveness (Phase 2)Study completedNCT05470114
What this trial is testing

A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD

Who this might be right for
Atopic Dermatitis
LEO Pharma 13
Testing effectiveness (Phase 2)Study completedNCT04313400
What this trial is testing

Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amytrx Therapeutics, Inc. 91
Not applicableLooking for participantsNCT07259343
What this trial is testing

Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population

Who this might be right for
Atopic Dermatitis (AD)
Universidad Autónoma de Aguascalientes 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06727552
What this trial is testing

Barzolvolimab in Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Celldex Therapeutics 131
Early research (Phase 1)Study completedNCT02647086
What this trial is testing

Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 14
Testing effectiveness (Phase 2)Study completedNCT06723405
What this trial is testing

Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)EczemaEczema Atopic Dermatitis
Evommune, Inc. 71
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation